PRSS50 and breast cancer: The IF assay results showed that overexpression or knockdown of TSP50 did not affect the nuclear translocation of β-catenin (Wnt/β-catenin signal factor) or NCID (Notch signal factor) in breast cancer cells (Fig. S5A-D).